Bolt Biotherapeutics is a clinical-stage biopharmaceutical company developing immune-stimulating antibody conjugates (ISACs) to harness the immune system against cancer. Its proprietary Boltbody ISAC platform combines tumor-targeting antibodies with immune-stimulating linker-payloads. Lead candidate BDC-4182 targets claudin 18.2 in gastric/gastroesophageal junction cancer and is in Phase 1 dose escalation. Other pipeline programs include a CEA ISAC, PD-L1 ISAC, and dectin-2 agonist antibody BDC-3042, currently on hold pending partnering or funding.
expected 2026-11-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001193125-26-104121 | EDGAR | 81K words |
| 2025-03-24 | 2024-12-31 | 0000950170-25-043873 | EDGAR | 85K words |
| 2024-03-21 | 2023-12-31 | 0000950170-24-034692 | EDGAR | 86K words |
| 2023-03-29 | 2022-12-31 | 0000950170-23-010613 | EDGAR | 86K words |
| 2022-03-30 | 2021-12-31 | 0000950170-22-005047 | EDGAR | 110K words |
| 2021-03-31 | 2020-12-31 | 0001193125-21-102253 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001193125-26-344597 | EDGAR | 21K words |
| 2025-11-12 | 2025-09-30 | 0001193125-25-277549 | EDGAR | 25K words |
| 2025-08-14 | 2025-06-30 | 0001641281-25-000007 | EDGAR | 24K words |
| 2025-05-12 | 2025-03-31 | 0000950170-25-069188 | EDGAR | 20K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125413 | EDGAR | 23K words |
| 2024-08-13 | 2024-06-30 | 0000950170-24-096200 | EDGAR | 23K words |
| 2024-05-14 | 2024-03-31 | 0000950170-24-059564 | EDGAR | 19K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062048 | EDGAR | 23K words |
| 2023-08-07 | 2023-06-30 | 0000950170-23-039061 | EDGAR | 24K words |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021233 | EDGAR | 22K words |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024487 | EDGAR | 24K words |
| 2022-08-10 | 2022-06-30 | 0000950170-22-016460 | EDGAR | 24K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001193125-26-344580 | EDGAR | 3K words |
| 2026-03-12 | 0001193125-26-104102 | EDGAR | 3K words |
| 2025-11-12 | 0001193125-25-277521 | EDGAR | 3K words |
| 2025-10-02 | 0001193125-25-228293 | EDGAR | 1K words |
| 2025-08-14 | 0001641281-25-000006 | EDGAR | 3K words |
| 2025-06-06 | 0000950170-25-083180 | EDGAR | 1K words |
| 2025-06-04 | 0000950170-25-081607 | EDGAR | 1K words |
| 2025-05-28 | 0000950170-25-077880 | EDGAR | 1K words |
| 2025-05-12 | 0000950170-25-069153 | EDGAR | 3K words |
| 2025-04-16 | 0000950170-25-054871 | EDGAR | 13K words |
74 total filings indexed. 46 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001641281 |
| Ticker | BOLT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.boltbio.com |
| Listed | 2021-02-05 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BOLT (~200 tokens, structured JSON with cryptographic provenance)